| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/05/2005 | US20050095291 Tamper-resistant oral opioid agonist formulations |
| 05/05/2005 | US20050095290 comprising pharmacologically active substance, drug absorbefacient and taurine compound or polyamine; suppressing or preventing damage of the intestinal mucous membrane |
| 05/05/2005 | US20050095285 Pharmaceutical composition and a process for its preparation |
| 05/05/2005 | US20050095282 Methods and compositions for inducing autoimmunity in the treatment of cancers |
| 05/05/2005 | US20050095272 Edible PGA coating composition |
| 05/05/2005 | US20050095271 Nutritional supplement containing carbohydrates, electrolytes, antioxidants, vitamins and amino acids; promoting fluid retention and reabsorption during exercise |
| 05/05/2005 | US20050095262 Multivitamin syrup for children or young adults |
| 05/05/2005 | US20050095251 Producing agent for inhibiting digestive enzymes within pancreas; expressing recombinant chimeric polypeptide in host cell and contacting with nucleophilic reagent and synthetic peptide containing cholecystokinin binding element |
| 05/05/2005 | US20050095232 Vaginal care composition |
| 05/05/2005 | US20050095224 Compositions and method for treating hepatitis virus infection |
| 05/05/2005 | US20050095216 Administering polypeptide drug that can be pegylated or conjugated to an oligomer; prodrugs, (conjugated)calcitonin or insulin; diabetes or osteoporosis treatment |
| 05/04/2005 | EP1527787A1 Immediate release tablet |
| 05/04/2005 | EP1527780A1 Stable solid formulation of enalapril salt and process for preparation thereof |
| 05/04/2005 | EP1527779A1 Sustained release ranolazine formulations |
| 05/04/2005 | EP1527775A1 Controlled release formulation containing tramadol |
| 05/04/2005 | EP1527773A1 Pharmaceutical composition comprising sumatriptan |
| 05/04/2005 | EP1527341A2 Interfacial biomaterials |
| 05/04/2005 | EP1527125A1 Porous beads and method of production thereof |
| 05/04/2005 | EP1527096A2 Binding molecules |
| 05/04/2005 | EP1526872A1 Polyalkylene glycol acid additives |
| 05/04/2005 | EP1526871A1 Oral administration of calcitonin |
| 05/04/2005 | EP1526866A2 Drug conjugate comprising an erythropoietin receptor ligand and an anticancer agent |
| 05/04/2005 | EP1526860A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 05/04/2005 | EP1526859A1 Process for preparing a sterile high molecular weight hyaluronic acid formulation |
| 05/04/2005 | EP1526847A2 Pharmaceutical dosage form comprising a sulfite compound |
| 05/04/2005 | EP1526846A2 Gelatin capsule exhibiting reduced cross-linking |
| 05/04/2005 | EP1526845A2 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 05/04/2005 | EP1526844A2 Pellicle-resistant gelatin capsule |
| 05/04/2005 | EP1526843A1 Method of preparing solid dosage forms coated in two layers comprising a water-insoluble polymer and a water-soluble pore former |
| 05/04/2005 | EP1526839A1 Oral pharmaceutical forms of liquid drugs having improved bioavailability |
| 05/04/2005 | EP1526838A1 Intravenous pharmaceutical form of administration |
| 05/04/2005 | EP1526835A1 Injectable depot compositions and uses thereof |
| 05/04/2005 | EP1465504B1 Matrix-forming composition containing pectin |
| 05/04/2005 | EP1465493A4 Cultured and encapsulated pancreatic stem cells |
| 05/04/2005 | EP1401466B1 Agent containing fat (oil), which contains onion extract, the production and use thereof for caring, preventing or treating damaged skin tissue, especially scarred tissue |
| 05/04/2005 | EP1214055B1 Pharmaceutical gel containing active substances |
| 05/04/2005 | EP1140017B9 Water-insoluble drug delivery system |
| 05/04/2005 | EP1139752B1 Methods and compositions for treatment of cell proliferative disorders |
| 05/04/2005 | EP1094790B9 Sustained release pharmaceutical preparation comprising phenytoin sodium |
| 05/04/2005 | EP1061955B1 Polynucleotide composition, method of preparation, and use thereof |
| 05/04/2005 | EP1032368B1 Iontophoretic devices comprising piperidin derivatives |
| 05/04/2005 | EP1028758B1 Radioactive compositions for the treatment of prostate tumors |
| 05/04/2005 | EP0859857B1 Cationic polyacrylates and poly(alkyl)acrylates or the corresponding acrylamides for use in synthetic transfection systems |
| 05/04/2005 | EP0835266B1 Modified/chimeric superantigens and their use |
| 05/04/2005 | EP0825858B1 Time-dependant release capsules containing omega-3 polyunsaturated acids for the treatment of inflammatory bowel disease |
| 05/04/2005 | CN1612934A Human monoclonal antibodies to dendritic cells |
| 05/04/2005 | CN1612895A Conjugates comprising an antibody specific for the ED-B domain of fibronectin and their use for the detection and treatment of tumours |
| 05/04/2005 | CN1612752A Aqueous sustained-release formulations of proteins |
| 05/04/2005 | CN1612748A Remedies for dry eye and diseases associated with dry eye |
| 05/04/2005 | CN1612737A Platinum derivative pharmaceutical formulations |
| 05/04/2005 | CN1612734A Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 05/04/2005 | CN1612726A Soluble drug extended release system |
| 05/04/2005 | CN1612725A Injectable depot composition |
| 05/04/2005 | CN1612724A Vascular occlusion solid-phase agent with immobilised platelet binding agent |
| 05/04/2005 | CN1612723A Local compositions containing enzymes stabilized with inhibitors |
| 05/04/2005 | CN1612717A Method and apparatus for production of a skin graft and the graft produced thereby |
| 05/04/2005 | CN1612689A Stable liquid pharmaceutical formulation of IgG antibodies |
| 05/04/2005 | CN1611524A Polyethylene glycol amino acid N-internal ring carbonyl anhydride active derivatives, and medicinal bonding compound and gel thereof |
| 05/04/2005 | CN1611513A Process of high purity albumin production |
| 05/04/2005 | CN1611216A Anti-fungus external-use agent for finger nail |
| 05/04/2005 | CN1611210A Non-water spraying agent |
| 05/04/2005 | CN1200028C Polyasparamide derivative and process for preparing its nano capsules |
| 05/04/2005 | CN1199695C Composition with carbohydrate matrix contaniing liposoluble substance |
| 05/04/2005 | CN1199694C Application of composite fat used as stabilizing additive in medicine of digestive enzyme mixture |
| 05/04/2005 | CN1199686C Sustained release compositions, process for producing the same and utilization thereof |
| 05/04/2005 | CN1199642C Novel medicinal compsns. containing cyclosporin |
| 05/04/2005 | CN1199623C Transdermal therapeutic system with nicotine and addition of monoterpene ketones |
| 05/04/2005 | CN1199567C Hybrid matrix implants and explants |
| 05/03/2005 | US6887976 Improved mammalian safety profile; glycopeptide phosphonate derivatives of invention unexpectedly exhibit reduced tissue accumulation and/or nephrotoxicity when administered to mammal; antibacterial agents |
| 05/03/2005 | US6887974 For preparing protein concentrates (fibrinogens rich compositions) from blood contacted with denaturant hydrogel; drug delivery |
| 05/03/2005 | US6887960 Graft copolymer of ethylenically unsaturated nonionic monomers and terminally unsaturated acrylic acid oligomers or polymers; drug delivery |
| 05/03/2005 | US6887906 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| 05/03/2005 | US6887888 Soluble compositions of triphenylethylene antiestrogens |
| 05/03/2005 | US6887882 Comprises (5bR-(5b-a,6b,12b-a))-5b,6,7,12b,13,14-hexahydro-13 -methyl(1,3)benzodioxolo(5,6c)-1,3-dioxolo(4,5-i)phenanthrid in-6-ol; for use as antiarrhythmic drugs; potassium channel modulators |
| 05/03/2005 | US6887861 Drug delivery |
| 05/03/2005 | US6887858 Method of treating dry eye disease with purinergic receptor agonists |
| 05/03/2005 | US6887857 Microparticle protection of therapeutic agents |
| 05/03/2005 | US6887852 Pharmaceutical preparation of recombinant factor VIII lyophilized without albumin as a stabilizer |
| 05/03/2005 | US6887842 Modulating a pharmacokinetic property of a drug by administering a bifunctional molecule containing the drug |
| 05/03/2005 | US6887674 Artery- and vein-specific proteins and uses therefor |
| 05/03/2005 | US6887502 Compositions comprising fat soluble substances in a glassy carbohydrate matrix |
| 05/03/2005 | US6887501 Isolated from cocoa beans; solvent extraction; nitric oxide synthase/lipoxygenase/cyclooxygenase modulators |
| 05/03/2005 | US6887490 Use in the delivery of therapeutic agents to selected tissues and advantageously has the potential to repair/replace damaged tissue |
| 05/03/2005 | US6887487 Injectable compositions for the controlled delivery of pharmacologically active compound |
| 05/03/2005 | US6887474 Compositions and methods for producing vascular occlusion |
| 05/03/2005 | US6887472 That do not cause anaphylaxis, antigenic fusion proteins of given amino acid sequence, of a CH3 domain of an immunoglobulin (IgE) molecule; allergy vaccines; vaccine test methods in dogs |
| 05/03/2005 | US6887468 Antibody kits for selectively inhibiting VEGF |
| 05/03/2005 | US6887462 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta (IFN-beata) |
| 05/03/2005 | US6887459 Administering inhalant with particulate carrier or diluent for treatment of chronic obstructive pulmonary disease |
| 05/03/2005 | US6887307 Pullulan film compositions |
| 05/03/2005 | US6887260 Method and apparatus for acne treatment |
| 05/03/2005 | US6886568 Method for fabricating cell-containing implants |
| 05/03/2005 | CA2486473A1 Vaginal care composition |
| 05/03/2005 | CA2390636C Stabilized formulations comprising amlodipine maleate |
| 05/03/2005 | CA2355657C Biodegradable ph/thermosensitive hydrogels for sustained delivery of biologically active agents |
| 05/03/2005 | CA2325045C Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same |
| 05/03/2005 | CA2245397C Antitumor agent |
| 05/03/2005 | CA2202531C Lyophilizate of lipid complex of water insoluble camptothecins |
| 05/03/2005 | CA2156708C Transmucosal delivery of macromolecular drugs |
| 04/28/2005 | WO2005051363A1 Coated conditioners for use in foods and pharmaceuticals |